Intuitive Surgical, Inc. $ISRG Position Increased by 111 Capital

111 Capital lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 94.9% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 3,542 shares of the medical equipment provider’s stock after buying an additional 1,725 shares during the quarter. 111 Capital’s holdings in Intuitive Surgical were worth $1,584,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Elo Mutual Pension Insurance Co boosted its holdings in shares of Intuitive Surgical by 1.5% during the third quarter. Elo Mutual Pension Insurance Co now owns 44,942 shares of the medical equipment provider’s stock valued at $20,099,000 after acquiring an additional 653 shares during the period. WASHINGTON TRUST Co lifted its position in Intuitive Surgical by 0.6% in the 3rd quarter. WASHINGTON TRUST Co now owns 43,367 shares of the medical equipment provider’s stock valued at $19,395,000 after purchasing an additional 253 shares during the last quarter. Cobblestone Capital Advisors LLC NY boosted its stake in Intuitive Surgical by 7.3% during the 3rd quarter. Cobblestone Capital Advisors LLC NY now owns 1,466 shares of the medical equipment provider’s stock valued at $656,000 after purchasing an additional 100 shares during the period. Fisher Asset Management LLC boosted its stake in Intuitive Surgical by 1.1% during the 3rd quarter. Fisher Asset Management LLC now owns 3,889,439 shares of the medical equipment provider’s stock valued at $1,739,475,000 after purchasing an additional 40,702 shares during the period. Finally, Davis R M Inc. grew its position in Intuitive Surgical by 24.0% in the 3rd quarter. Davis R M Inc. now owns 51,596 shares of the medical equipment provider’s stock worth $23,075,000 after purchasing an additional 9,982 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.7%

Shares of NASDAQ:ISRG opened at $503.51 on Monday. The company’s fifty day moving average is $529.83 and its two-hundred day moving average is $511.92. The company has a market cap of $178.81 billion, a P/E ratio of 63.82, a price-to-earnings-growth ratio of 3.88 and a beta of 1.66. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. The business had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company posted $2.21 earnings per share. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. Wells Fargo & Company increased their price target on Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a research note on Friday, December 12th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. UBS Group set a $570.00 target price on shares of Intuitive Surgical and gave the company a “neutral” rating in a research report on Tuesday, February 24th. Barclays set a $712.00 target price on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Finally, Sanford C. Bernstein upped their price target on shares of Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.86.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at $496,455.52. This represents a 83.23% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Myriam Curet sold 421 shares of the business’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the transaction, the executive vice president owned 409 shares in the company, valued at approximately $202,438.64. The trade was a 50.72% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 33,603 shares of company stock worth $17,875,660 in the last three months. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.